Quarterly report · Q3
4886.TEDINET S100Q4CE
Period2022-04-01 → 2022-12-31
Filed2023-02-09
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥47.3bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥56.6bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥44.2bn | 2021-04-01 → 2021-12-31 | Cons. | Net sales |
| Operating income | ¥5.0bn | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Operating income | ¥4.7bn | 2021-04-01 → 2021-12-31 | Cons. | Operating income |
| Ordinary income | ¥5.2bn | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥4.9bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.8bn | 2021-04-01 → 2021-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥5.4bn | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥5.8bn | 2021-04-01 → 2021-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥4.2bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥4.3bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥4.1bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥4.2bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Net income | ¥4.1bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss |
| Total assets | ¥90.8bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥83.3bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥87.5bn | at 2021-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥36.7bn | at 2022-12-31 | Cons. | Liabilities |
| Total liabilities | ¥34.4bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥54.1bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥48.9bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥48.4bn | at 2021-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥18.5bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥12.1bn | at 2022-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥148.19 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥64.97 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥151.22 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥143.76 | 2021-04-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥242.1 | 2021-10-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 59.6% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 58.7% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.3% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 34
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-12-31 | ¥196m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-12-31 | ¥155m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥41m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-12-31 | −¥26m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-12-31 | −¥41m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-12-31 | −¥41m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-12-31 | −¥767m |
| jpcrp040300-q3r_E35791-000Animal Health Businessreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥5.2bn |
| jpcrp040300-q3r_E35791-000Animal Health Businessreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥5.2bn |
| jpcrp040300-q3r_E35791-000Animal Health Businessreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥417m |
| jpcrp040300-q3r_E35791-000Pharmaceutical Businessreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥41.9bn |
| jpcrp040300-q3r_E35791-000Pharmaceutical Businessreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥41.9bn |
| jpcrp040300-q3r_E35791-000Pharmaceutical Businessreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥5.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-12-31 | ¥47.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-12-31 | ¥47.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥41m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-12-31 | ¥5.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2021-12-31 | ¥158m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2021-12-31 | ¥116m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥41m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-12-31 | −¥42m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-12-31 | −¥41m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-12-31 | −¥41m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-12-31 | −¥495m |
| jpcrp040300-q3r_E35791-000Animal Health Businessreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥4.4bn |
| jpcrp040300-q3r_E35791-000Animal Health Businessreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥4.4bn |
| jpcrp040300-q3r_E35791-000Animal Health Businessreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥329m |
| jpcrp040300-q3r_E35791-000Pharmaceutical Businessreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥39.7bn |
| jpcrp040300-q3r_E35791-000Pharmaceutical Businessreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥39.7bn |
| jpcrp040300-q3r_E35791-000Pharmaceutical Businessreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥4.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-12-31 | ¥44.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-12-31 | ¥44.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥41m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-12-31 | ¥5.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 340
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 2269100 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0742 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 2269100 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 2269100 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.0742 | |
| Cash and deposits | Prior1YearInstant | 12103000000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 18504000000 | JPY |
| Notes and accounts receivable trade and contract assets | Prior1YearInstant | 14482000000 | JPY |
| Notes and accounts receivable trade and contract assets | CurrentQuarterInstant | 18148000000 | JPY |
| Short term investment securities | Prior1YearInstant | 5000000000 | JPY |
| Short term investment securities | CurrentQuarterInstant | － | JPY |
| Merchandise and finished goods | Prior1YearInstant | 10016000000 | JPY |
| Merchandise and finished goods | CurrentQuarterInstant | 10188000000 | JPY |
| Work in process | Prior1YearInstant | 457000000 | JPY |
| Work in process | CurrentQuarterInstant | 252000000 | JPY |
| Raw materials and supplies | Prior1YearInstant | 4587000000 | JPY |
| Raw materials and supplies | CurrentQuarterInstant | 7208000000 | JPY |
| Other ca | Prior1YearInstant | 2911000000 | JPY |
| Other ca | CurrentQuarterInstant | 3123000000 | JPY |
| Allowance for doubtful accounts ca | Prior1YearInstant | -0 | JPY |
| Allowance for doubtful accounts ca | CurrentQuarterInstant | － | JPY |
| Current assets | Prior1YearInstant | 49557000000 | JPY |
| Current assets | CurrentQuarterInstant | 57426000000 | JPY |
| Property plant and equipment | Prior1YearInstant | 10936000000 | JPY |
| Property plant and equipment | CurrentQuarterInstant | 11000000000 | JPY |
| Intangible assets | Prior1YearInstant | 6183000000 | JPY |
| Intangible assets | CurrentQuarterInstant | 4716000000 | JPY |
| Investment securities | Prior1YearInstant | 12223000000 | JPY |
| Investment securities | CurrentQuarterInstant | 13782000000 | JPY |
| Other ioa | Prior1YearInstant | 4414000000 | JPY |
| Other ioa | CurrentQuarterInstant | 3885000000 | JPY |
| Allowance for doubtful accounts ioa by group | Prior1YearInstant | -17000000 | JPY |
| Allowance for doubtful accounts ioa by group | CurrentQuarterInstant | -17000000 | JPY |
| Investments and other assets | Prior1YearInstant | 16620000000 | JPY |
| Investments and other assets | CurrentQuarterInstant | 17650000000 | JPY |
| Noncurrent assets | Prior1YearInstant | 33739000000 | JPY |
| Noncurrent assets | CurrentQuarterInstant | 33368000000 | JPY |
| Assets | Prior1YearInstant | 83297000000 | JPY |
| Assets | CurrentQuarterInstant | 90794000000 | JPY |
| Notes and accounts payable trade | Prior1YearInstant | 3118000000 | JPY |
| Notes and accounts payable trade | CurrentQuarterInstant | 5959000000 | JPY |
| Electronically recorded obligations operating cl | Prior1YearInstant | 3723000000 | JPY |
| Electronically recorded obligations operating cl | CurrentQuarterInstant | 2721000000 | JPY |
| Short term loans payable | Prior1YearInstant | 1723000000 | JPY |
| Short term loans payable | CurrentQuarterInstant | 3343000000 | JPY |
| Other provision cl | Prior1YearInstant | 1188000000 | JPY |
| Other provision cl | CurrentQuarterInstant | 554000000 | JPY |
| Other cl | Prior1YearInstant | 6257000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |